Photo: Jeff Porter/AHCJSeema Verma, administrator for the Centers for Medicare and Medicaid Services, spoke at a briefing on public health emergencies at the CDC in December.
Seema Verma, administrator for the Centers for Medicare and Medicaid Services, was on defense on Thursday during a meeting with reporters who pushed her to explain a series of controversial decisions made by her agency in recent weeks.
The agency has faced accusations of sabotage by health advocates after the agency’s decisions to end risk payments to insurance companies offering plans on the individual market and to dramatically cut funding for navigators who help consumers sign up for coverage. Continue reading
Photo: Jeff Porter/AHCJSeema Verma, administrator for the Centers for Medicare and Medicaid Services, speaks at a past briefing.
The Centers for Medicare and Medicaid Services announced initiatives today intended to improve oversight and the integrity of Medicaid.
CMS will implement “stronger audit functions, enhanced oversight of state contracts with private insurance companies, increased beneficiary eligibility oversight, and stricter enforcement of state compliance with federal rules,” according to a press release. Continue reading
The new assistant secretary for public affairs at the U.S. Department of Health and Human Services wants to improve the agency’s outreach to regional reporters and plans to hire a liaison devoted to working with journalists outside the Beltway.
Judy Stecker, appointed to the role in April, mentioned the new emphasis on reaching regional reporters in a phone call last week with the chairs of AHCJ’s Right to Know Committee. Continue reading
Today the Centers for Medicare and Medicaid announced a “Scorecard” intended to increase public transparency about the performance of the agency’s programs.
The site uses data that was voluntarily submitted by states on “selected health and program indicators.” An introduction to the site says it offers information about these questions: Continue reading
Last week, President Trump spoke about his plans to lower prescription drug prices by increasing competition and creating incentives for them to lower prices.
His plan includes budget proposals to reform the Medicare Part D program, curbing abuse of FDA safety rules and continuing generic drug approvals,